Dese de alta para crear alertas sobre sus instrumentos,
eventos económicos y autores favoritos
Registrarse gratis ¿Ya tiene una cuenta? Iniciar sesión
49,57
-0,12
-0,24%
Cotizaciones
Todos los instrumentos
- Todos los instrumentos
- Índices
- Acciones
- ETFs
- Fondos
- M. primas
- Divisas
- Cripto
- Bonos
- Certificados
Por favor, inténtelo con una nueva búsqueda
Pgim Jennison Health Sciences Fund- Class Z (PHSZX)
Añadir/Eliminar de la cartera
Añadir a cartera
- Rating de Morningstar:
- Total activos: 929,16M
Tipo:
Fondo
Mercado:
Estados Unidos
Emisor:
Prudential Funds (PGIM Investments)
Clase de activo:
Acción
Prudential Jennison Health Sciences Z
49,57
-0,12
-0,24%
Resumen PHSZX
En esta página encontrará un perfil detallado de Pgim Jennison Health Sciences Fund- Class Z. Conozca la gestión clave, los activos totales, la estrategia de inversión y la información de contacto de PHSZX, entre otros datos.
Información de contacto
Lugar
One Seaport Plaza
New York,NY 10292
United States
New York,NY 10292
United States
Teléfono fijo
+1 8002251852
Ejecutivos destacados
| Nombre | Título | Desde | Hasta |
|---|---|---|---|
| Daniel Matviyenko | Managing Director | 2020 | Ahora |
| Biografía | Dan Matviyenko is a portfolio manager for Jennison’s healthcare strategies. He is responsible for overseeing the investment process, strategy implementation, and risk management for all healthcare strategies. Before joining Jennison in 2020, Dan was with Malleus Capital as founder, chief investment officer, and portfolio manager. Prior to that, he held various senior positions at Tudor Investment as partner and portfolio manager as well as at UBS O’Connor as an executive director and portfolio manager. Dan received a BS in finance from the University of Connecticut. | ||
| Debra Netschert | Managing Director | 2015 | Ahora |
| Biografía | Debra Netschert is a portfolio manager for Jennison’s healthcare strategies. She is responsible for overseeing the investment process, strategy implementation, and risk management for all healthcare strategies. Before joining Jennison in 2008, she was with Magnetar Capital as a senior analyst specializing in health care. Prior to that, she worked at Amaranth Advisors focusing on biopharmaceuticals and at Lazard Capital Markets covering biotechnology. Debra began her research career as an associate biotechnology analyst at UBS. She received a BS in health science and MS in physical therapy from Boston University. | ||
| David Chan | Portfolio Manager | 1999 | 2022 |
| Biografía | David Chan, CFA, is a Managing Director and a Health Sciences Equity Portfolio Manager and Research Analyst of Jennison. Mr. Chan joined Jennison Associates in May 1992. He was previously with the Boston Consulting Group, where he was a team leader and consultant on projects in a wide variety of industries, but with a special focus in the health care area. Mr. Chan has also worked in various positions in the film and television industry. He received a BA in biochemistry from Harvard University and an MBA from Columbia University. | ||
| Michael A. Del Balso | Director | 2000 | 2017 |
| Biografía | Michael Del Balso is a large cap growth portfolio manager. He joined Jennison in 1972 as a research analyst. He later served as the director of research and became a portfolio manager in 1999. Prior to Jennison, he was a portfolio manager and research analyst at White, Weld & Company. Michael received a BS in industrial administration from Yale University and an MBA from Columbia University Business School. | ||
| John Van Belle | Managing Director | 1999 | 2002 |
| Biografía | John Van Belle, PhD, is a Managing Director and Portfolio Manager for QMA working within the Quantitative Equity team. In this capacity, he manages global and non-US portfolios. Prior to joining QMA, John taught Economics and Finance at the University of Virginia and Rutgers Graduate School of Management and was a Vice President in Currency Management Consulting at both Bankers Trust and Citibank. Previously, he worked in the Research department of the Federal Reserve Bank of New York. He has published numerous articles in the fields of Economics and Finance. John earned a BS in Economics from St. Joseph's College and a PhD in Economics from the University of Virginia. | ||
| Kathleen A. McCarragher | Managing Director | 1999 | 2000 |
| Biografía | Kathleen McCarragher is the head of growth equity and a large cap growth equity portfolio manager. She is responsible for overseeing the investment process, strategy implementation, and risk management for Jennison's growth equity platform. Kathleen is also a member of the Jennison Management Team, ESG Investment Leadership Team, and Jennison Board of Directors. Before joining Jennison in 1998, she was a managing director and the director of large cap growth equities with Weiss, Peck & Greer. Prior to that, she was an investor with State Street Research & Management. Kathleen received a BBA, summa cum laude, in finance and economics from the University of Wisconsin-Eau Claire and an MBA from Harvard Business School. | ||
Escribe tu comentario sobre Pgim Jennison Health Sciences Fund- Class Z
¿Estás seguro que quieres borrar este gráfico?
Eliminar Cancelar
¿Sustituir el gráfico adjunto por un nuevo gráfico?
Sustituir Cancelar
Guía para comentarios
Adjuntar un gráfico al comentario
Confirmar bloqueo
¿Está seguro de que desea bloquear a %USER_NAME%?
Al hacerlo, ni usted ni %USER_NAME% podrán ver las publicaciones del otro en Investing.com.
Se ha agregado correctamente a %USER_NAME% a su lista de usuarios bloqueados
Acaba de desbloquear a esta persona; tiene que esperar 48 horas para poder bloquearla de nuevo.
Denunciar este comentario
Díganos qué piensa de este comentario
Comentario denunciado
Gracias
Su denuncia será examinada por nuestros moderadores